Zelluna ASA: Approval and publication of prospectus
15 januari, 12:22
15 januari, 12:22
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Oslo, 15 January 2026: Reference is made to the stock exchange announcement by Zelluna ASA (“Zelluna” or the “Company”) on 3 November 2025 regarding the successful private placement of 5,500,000 new shares and the allocation of 315,639 new shares in the retail offering carried out via the PrimaryBid platform (collectively, the "NewShares").
The Company has prepared a prospectus for the listing of New Shares. The prospectus has today been approved by the Financial Supervisory Authority of Norway, and will be made available at the Company's website https://zelluna.com/investors/presentations-and-publications.
For further information, please contact:
Namir Hassan, CEO, Zelluna ASA
Email: namir.hassan@zelluna.com
Phone: +44 7720 687608
Anders Tuv, Chairman, Zelluna ASA
Email: at@radforsk.no
Phone: +47 982 06 826

15 januari, 12:22
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Oslo, 15 January 2026: Reference is made to the stock exchange announcement by Zelluna ASA (“Zelluna” or the “Company”) on 3 November 2025 regarding the successful private placement of 5,500,000 new shares and the allocation of 315,639 new shares in the retail offering carried out via the PrimaryBid platform (collectively, the "NewShares").
The Company has prepared a prospectus for the listing of New Shares. The prospectus has today been approved by the Financial Supervisory Authority of Norway, and will be made available at the Company's website https://zelluna.com/investors/presentations-and-publications.
For further information, please contact:
Namir Hassan, CEO, Zelluna ASA
Email: namir.hassan@zelluna.com
Phone: +44 7720 687608
Anders Tuv, Chairman, Zelluna ASA
Email: at@radforsk.no
Phone: +47 982 06 826

Analyser

Japan
Rapporter
Novo Nordisk
Aktier
Analyser

Japan
Rapporter
Novo Nordisk
Aktier
SKAGEN Kon-Tiki
Idag, 16:37
Tillväxtmarknader i förändring – därför fortsätter SKAGEN Kon-Tiki att leverera
Humana
Idag, 16:01
Humana: Går aktien att räkna hem?
Investor
Idag, 11:12
Investor allt mer ett industribolag
OMX Stockholm 30
1 DAG %
Senast
3 136,54